Literature DB >> 27132474

Partial deletion of TCF4 in three generation family with non-syndromic intellectual disability, without features of Pitt-Hopkins syndrome.

Mira Kharbanda1, Kaja Kannike2, Anne Lampe3, Jonathan Berg4, Tõnis Timmusk2, Mari Sepp2.   

Abstract

Mutations in TCF4 (basic helix-loop-helix transcription factor 4), a gene with complex organization and multiple transcription initiation sites, are usually associated with Pitt-Hopkins syndrome (PTHS). However, a translocation encompassing the 5' end of TCF4 and several point mutations have been linked to non-syndromic intellectual disability (NSID). Here we describe a family with autosomal dominantly inherited NSID in seven relatives with a partial deletion of TCF4, disrupting the 5' end of the gene, predicted to result in the reduction of the number of mRNAs that can be produced by alternative transcription initiation. Functional studies indicate that it leads to reduced levels of transcripts coding for TCF4 protein isoforms with a nuclear localization signal, which may be relevant to the phenotype. The findings in our family support the notion that the position of the mutation in TCF4 is relevant to the phenotype, with those mutations in the 5' region, cassette exons and regions not affecting the important functional domains being linked to NSID rather than PTHS. We suggest that screening for mutations in TCF4 could be considered in the investigation of NSID.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Alternative transcription; Non-syndromic intellectual disability; Pitt-Hopkins syndrome; TCF4

Mesh:

Substances:

Year:  2016        PMID: 27132474     DOI: 10.1016/j.ejmg.2016.04.003

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  15 in total

Review 1.  Pitt-Hopkins Syndrome: A Review of Current Literature, Clinical Approach, and 23-Patient Case Series.

Authors:  Kimberly Goodspeed; Cassandra Newsom; Mary Ann Morris; Craig Powell; Patricia Evans; Sailaja Golla
Journal:  J Child Neurol       Date:  2018-01-10       Impact factor: 1.987

2.  The Intellectual Disability and Schizophrenia Associated Transcription Factor TCF4 Is Regulated by Neuronal Activity and Protein Kinase A.

Authors:  Mari Sepp; Hanna Vihma; Kaja Nurm; Mari Urb; Stephanie Cerceo Page; Kaisa Roots; Anu Hark; Brady J Maher; Priit Pruunsild; Tõnis Timmusk
Journal:  J Neurosci       Date:  2017-09-26       Impact factor: 6.167

3.  WNT/β-Catenin Pathway and Epigenetic Mechanisms Regulate the Pitt-Hopkins Syndrome and Schizophrenia Risk Gene TCF4.

Authors:  Krista M Hennig; Daniel M Fass; Wen-Ning Zhao; Steven D Sheridan; Ting Fu; Serkan Erdin; Alexei Stortchevoi; Diane Lucente; Jannine D Cody; David Sweetser; James F Gusella; Michael E Talkowski; Stephen J Haggarty
Journal:  Mol Neuropsychiatry       Date:  2017-07-14

4.  Disease-causing variants in TCF4 are a frequent cause of intellectual disability: lessons from large-scale sequencing approaches in diagnosis.

Authors:  Laura Mary; Amélie Piton; Elise Schaefer; Francesca Mattioli; Elsa Nourisson; Claire Feger; Claire Redin; Magali Barth; Salima El Chehadeh; Estelle Colin; Christine Coubes; Laurence Faivre; Elisabeth Flori; David Geneviève; Yline Capri; Laurence Perrin; Jennifer Fabre-Teste; Dana Timbolschi; Alain Verloes; Robert Olaso; Anne Boland; Jean-François Deleuze; Jean-Louis Mandel; Bénédicte Gerard; Irina Giurgea
Journal:  Eur J Hum Genet       Date:  2018-04-26       Impact factor: 4.246

5.  Molecular Mechanisms of Transcription Factor 4 in Pitt Hopkins Syndrome.

Authors:  Matthew D Rannals; Brady J Maher
Journal:  Curr Genet Med Rep       Date:  2017-02-11

6.  Distinct selective forces and Neanderthal introgression shaped genetic diversity at genes involved in neurodevelopmental disorders.

Authors:  Alessandra Mozzi; Diego Forni; Rachele Cagliani; Uberto Pozzoli; Mario Clerici; Manuela Sironi
Journal:  Sci Rep       Date:  2017-07-21       Impact factor: 4.379

7.  Deconvolution of transcriptional networks identifies TCF4 as a master regulator in schizophrenia.

Authors:  Abolfazl Doostparast Torshizi; Chris Armoskus; Hanwen Zhang; Marc P Forrest; Siwei Zhang; Tade Souaiaia; Oleg V Evgrafov; James A Knowles; Jubao Duan; Kai Wang
Journal:  Sci Adv       Date:  2019-09-11       Impact factor: 14.136

Review 8.  Molecular and Cellular Function of Transcription Factor 4 in Pitt-Hopkins Syndrome.

Authors:  Huei-Ying Chen; Joseph F Bohlen; Brady J Maher
Journal:  Dev Neurosci       Date:  2021-06-16       Impact factor: 3.421

9.  Region and Cell Type Distribution of TCF4 in the Postnatal Mouse Brain.

Authors:  Hyojin Kim; Noah C Berens; Nicole E Ochandarena; Benjamin D Philpot
Journal:  Front Neuroanat       Date:  2020-07-17       Impact factor: 3.856

Review 10.  Prioritization of Variants Detected by Next Generation Sequencing According to the Mutation Tolerance and Mutational Architecture of the Corresponding Genes.

Authors:  Iria Roca; Ana Fernández-Marmiesse; Sofía Gouveia; Marta Segovia; María L Couce
Journal:  Int J Mol Sci       Date:  2018-05-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.